Spruce Biosciences, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +1,100.0% | +200.0% | +88.9% | +8.8% | -5.4% | -34.3% | -54.3% | |
| – | +94.1% | +285.2% | +424.2% | -8.3% | +27.3% | +15.7% | -51.9% | |
| – | +94.1% | +318.9% | +435.0% | -16.4% | – | – | – | |
| – | -77.8% | +342.2% | +68.1% | -42.1% | +814.8% | -182.8% | – | |
| – | +0.0% | +1,750.0% | +25.7% | -91.4% | -12.5% | -100.0% | – | |
| – | +0.0% | +1,750.0% | +106,883.8% | – | +135.4% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | -99.9% | -129.9% | +677.5% | – | -62.1% | |
| – | +0.0% | -94.9% | +0.0% | -100.0% | – | +0.0% | +26.8% | |
| – | +0.0% | +1,356.1% | -99.6% | -137.5% | – | -103.3% | – | |
| – | – | – | -174.6% | – | – | -180.4% | – | |
| – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.